Presented by Finance Advisors: Don’t invest alone. Take this 60-second quiz to connect with an advisor who can help you see your whole wealth picture. Get started here.

The pattern this morning is mostly about who is finally getting credit and who is finally getting punished. The AI buildout is no longer just a chip story, with adjacent hardware and power names now visibly pulling through. Consumer brands that cracked the turnaround code are getting paid for it, while the names trading on momentum alone are finding out what happens when the bar gets reset.

On the other side, guidance cuts and cost surprises are doing more damage than misses. A glass packager reset its full-year math by roughly a third, a rental car operator watched its earnings power get cut nearly in half, and a retail trading platform missed at exactly the moment its narrative needed to hold. The split this morning is clean: clear stories getting rewarded, broken ones getting punished, and very little in between.

Making money is one thing. Keeping it is another.

Without a plan, taxes, volatility, and bad decisions can undo your progress.

Take this short quiz, and we’ll match you with a vetted advisor who can help you:

60-second quiz. Free call.

No pressure. Just clarity.

NXP Semiconductors (NXPI): +19.1%

The chipmaker beat on the top and bottom lines and guided current-quarter revenue and earnings above consensus. After a long stretch where auto and industrial chip names were stuck in the AI shadow, NXPI is finally getting credit for a cleaner setup.

Bloom Energy (BE): +18.1%

The fuel cell maker delivered a clean beat and raised its full-year revenue and earnings outlook above where analysts were modeling. With AI data centers scrambling for any reliable power source they can find, Bloom is sitting in exactly the right place at the right time.

Seagate Technology (STX): +15.9%

The data storage company guided next-quarter revenue well above where the street had it modeled, a signal that the AI buildout is now visibly pulling through to legacy storage suppliers. The move dragged the rest of the memory complex higher, with WDC, SNDK, and MU all riding the wave.

Rush Street Interactive (RSI): +15.5%

The online casino and sports betting operator beat on both lines and raised full-year guidance above expectations. In a sector where everyone is fighting for share, raising the bar mid-year is the cleanest signal a company can send.

Generac (GNRC): +9.6%

The backup power maker beat handily on earnings and revenue, though capex came in more than double what analysts expected. The market is reading the spending as Generac leaning into a demand cycle, not running away from one.

O-I Glass (OI): -18.8%

The glass packaging maker slashed its full-year earnings guidance by roughly a third and missed on the quarter. When a company resets the bar this hard, investors usually assume there's more bad news to come.

Avis Budget Group (CAR): -18.1%

The rental car company missed adjusted EBITDA, with earnings per share collapsing from $14.35 a year ago to $8.01. The fleet costs that were supposed to normalize haven't, and the market is starting to wonder if they ever will.

Robinhood (HOOD): -11.1%

The retail trading platform missed on both earnings and revenue. After a year where HOOD became the poster child for every "retail is back" narrative, missing the bar is a sharper rebuke than the headline number suggests.

You’re getting Top Tickers, you’re trading smarter. But what’s your plan after you cash in?

Without a smart wealth strategy, gains can disappear faster than they grow. That’s why we’ve made it simple to connect with a trusted, vetted advisor who can help you:

This quiz only takes 30 seconds to get matched—and your first call is completely free, with zero obligation.

Make sure your wins today fuel your future success.

Eli Lilly (LLY)

Lilly reports tomorrow morning, and the chatter has been building all week as the GLP-1 cohort waits for its first real read-through of the year. The stock slid almost 4% on Friday after weak early prescription data on Foundayo, the oral obesity pill that just got FDA approved on April 1, and retail has been openly debating whether the slow ramp is a launch hiccup or the first crack in the franchise.

Mounjaro and Zepbound combined to deliver roughly 56% of last year's revenue, so the split between them and any color on Foundayo uptake will set the tone for the entire weight-loss complex. With pharma untouched in this week's mega-cap earnings parade, tomorrow's print could either reset the GLP-1 narrative or hand the bears their first real datapoint.

✌️That’s it for today.